FAS and Hodgkins lymphoma: Dotti et al. reported that EBV-CTLs are highly sensitive to Fas/FasL-mediated apoptosis and that knockdown of Fas significantly improve the efficacy of EBV-CTLs in NPC and Hodgkin lymphoma [212].